A Comprehensive Analysis of Tn and STn Antigen Expression in Esophageal Adenocarcinoma
Mercanoglu B, Karstens K, Giannou A, Meiners J, Lücke J, Seeger P, Brackrock V, Güngör C, Izbicki J, Bockhorn M, Hackert T, Melling N, Wolters-Eisfeld G
CANCERS. 2024;16(2):.

Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience
Grass J, Küsters N, Kemper M, Tintrup J, Piecha F, Izbicki J, Perez D, Melling N, Bockhorn M, Reeh M
PLOS ONE. 2022;17(3):e0265093.

Morphologic Factors Predict Pain Relief Following Pancreatic Head Resection in Chronic Pancreatitis Description of the Chronic Pancreatitis Pain Relief (CPPR) Score
Bachmann K, Melling N, Groteluschen R, Fleischauer A, Reeh M, Ghadban T, Bockhorn M, Izbicki J
ANN SURG. 2021;273(4):800-805.

Truncated O-GalNAc glycans impact on fundamental signaling pathways in pancreatic cancer
Hofmann B, Picksak A, Kwiatkowski M, Grupp K, Jücker M, Bachmann K, Mercanoglu B, Izbicki J, Kahlert C, Bockhorn M, Güngör C, Ewald F, Wolters-Eisfeld G
GLYCOBIOLOGY. 2021;2021:.

Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma
Jacobsen F, Kohsar J, Gebauer F, Kluth M, Hube-Magg C, Simon R, Bockhorn M, Hinsch A, Burandt E, Lübke A, Steurer S, Tachezy M, Sauter G, Izbicki J, Wilczak W, Melling N
ONCOTARGET. 2020;11(12):1007-1016.

Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival
Karstens K, Kempski J, Giannou A, Pelczar P, Steglich B, Steurer S, Freiwald E, Woestemeier A, Konczalla L, Tachezy M, Reeh M, Bockhorn M, Perez D, Mann O, Lohse A, Roesch T, Izbicki J, Gagliani N, Huber S
CANCER IMMUNOL IMMUN. 2020;69(6):1043-1056.

The decrease of BMI and albumin levels influences the rate of anastomotic leaks in patients following reconstruction after emergency diverting esophagectomy
Karstens K, Stüben B, Ghadban T, Uzunoglu F, Bachmann K, Bockhorn M, Izbicki J, Reeh M
ESOPHAGUS-TOKYO. 2020;17(2):183-189.

Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer
Konczalla L, Perez D, Wenzel N, Wolters-Eisfeld G, Klemp C, Lüddeke J, Wolski A, Landschulze D, Meier C, Buchholz A, Yao D, Hofmann B, Graß J, Spriestersbach S, Grupp K, Schumacher U, Betzel C, Kapis S, Nuguid T, Steinberg P, Püschel K, Sauter G, Bockhorn M, Uzunoglu F, Izbicki J, Güngör C, El Gammal A
INT J CANCER. 2020;146(6):1618-1630.

Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)
Miao Y, Lu Z, Yeo C, Vollmer C, Fernandez-Del Castillo C, Ghaneh P, Halloran C, Kleeff J, de Rooij T, Werner J, Falconi M, Friess H, Zeh H, Izbicki J, He J, Laukkarinen J, Dejong C, Lillemoe K, Conlon K, Takaori K, Gianotti L, Besselink M, Del Chiaro M, Montorsi M, Tanaka M, Bockhorn M, Adham M, Oláh A, Salvia R, Shrikhande S, Hackert T, Shimosegawa T, Zureikat A, Ceyhan G, Peng Y, Wang G, Huang X, Dervenis C, Bassi C, Neoptolemos J, Büchler M
SURGERY. 2020;168(1):72-84.

Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method
Woestemeier A, Harms-Effenberger K, Karstens K, Konczalla L, Ghadban T, Uzunoglu F, Izbicki J, Bockhorn M, Pantel K, Reeh M
CANCERS. 2020;12(3):718.

Aberrant expression of Sec61α in esophageal cancers
Bachmann K, Bockhorn M, Mann O, Gebauer F, Blessmann M, Izbicki J, Grupp K
J CANCER RES CLIN. 2019;145(8):2039-2044.

High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients
El Gammal A, Melling N, Reeh M, Gebauer F, Mann O, Perez D, Bockhorn M, Bachmann K, Izbicki J, Grupp K
EXP MOL PATHOL. 2019;107:51-56.

Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality
Ghadban T, Reeh M, Bockhorn M, Grotelueschen R, Bachmann K, Grupp K, Uzunoglu F, Izbicki J, Perez D
CANCER MANAG RES. 2019;11:2101-2107.

C-Reactive Protein in the Prediction of Localization of Gastrointestinal Perforation
Grupp K, Grotelüschen R, Uzunoglu F, Hofmann B, König A, Perez D, Bockhorn M, Izbicki J, Bachmann K
EUR SURG RES. 2019;60(5-6):179-185.

Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer
Kemper M, Strohm T, Grupp K, Ghadban T, Bogoevski D, Bachmann K, Bockhorn M, Sauter G, Izbicki J, Reeh M
ANTICANCER RES. 2019;39(3):1191-1196.

Prospective Comparison of the Prognostic Relevance of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow of a Single Patient's Cohort With Esophageal Cancer
Konczalla L, Ghadban T, Effenberger K, Wöstemeier A, Riethdorf S, Uzunoglu F, Izbicki J, Pantel K, Bockhorn M, Reeh M
ANN SURG. 2019;273(2):299-305.

RAI3 is overexpressed in gastric adenocarcinoma but unrelated to prognosis
Melling N, Bachmann K, Bockhorn M, Mann O, Izbicki J, Grupp K
INT J CLIN EXP PATHO. 2019;12(2):606-612.

p53 overexpression is a prognosticator of poor outcome in esophageal cancer
Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F
ONCOL LETT. 2019;17(4):3826-3834.

Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort
Uzunoglu F, Welte M, Gavazzi F, Maggino L, Perinel J, Salvia R, Janot M, Reeh M, Perez D, Montorsi M, Zerbi A, Adham M, Uhl W, Bassi C, Izbicki J, Malleo G, Bockhorn M
EJSO-EUR J SURG ONC. 2019;45(5):793-799.

Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging
Well L, Salamon J, Kaul M, Farschtschi S, Herrmann J, Geier K, Hagel C, Bockhorn M, Bannas P, Adam G, Mautner V, Derlin T
NEURO-ONCOLOGY. 2019;21(4):508-516.

Establishment of the First Well-differentiated Human Pancreatic Neuroendocrine Tumor Model
Benten D, Behrang Y, Unrau L, Weissmann V, Wolters-Eisfeld G, Burdak-Rothkamm S, Stahl F, Anlauf M, Grabowski P, Möbs M, Dieckhoff J, Sipos B, Fahl M, Eggers C, Perez D, Bockhorn M, Izbicki J, Lohse A, Schrader J
MOL CANCER RES. 2018;16(3):496-507.

Improved risk stratification by circulating tumor cell counts in pancreatic cancer
Effenberger K, Schroeder C, Hanssen A, Wolter S, Eulenburg C, Tachezy M, Gebauer F, Izbicki J, Pantel K, Bockhorn M
CLIN CANCER RES. 2018;24(12):2844-2850.

Minimally invasive surgery for colorectal cancer remains underutilized in Germany despite its nationwide application over the last decade
Ghadban T, Reeh M, Bockhorn M, Heumann A, Grotelueschen R, Bachmann K, Izbicki J, Perez D
SCI REP-UK. 2018;8(1):15146.

Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS)
Gianotti L, Besselink M, Sandini M, Hackert T, Conlon K, Gerritsen A, Griffin O, Fingerhut A, Probst P, Abu Hilal M, Marchegiani G, Nappo G, Zerbi A, Amodio A, Perinel J, Adham M, Raimondo M, Asbun H, Sato A, Takaori K, Shrikhande S, Del Chiaro M, Bockhorn M, Izbicki J, Dervenis C, Charnley R, Martignoni M, Friess H, de Pretis N, Radenkovic D, Montorsi M, Sarr M, Vollmer C, Frulloni L, Büchler M, Bassi C
SURGERY. 2018;164(5):1035-1048.

FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas
Grupp K, Uzunoglu F, Melling N, Hofmann B, El Gammal A, Grotelüschen R, Heumann A, Bellon E, Reeh M, Wolters-Eisfeld G, Ghabdan T, Nentwich M, Bachmann K, Bockhorn M, Bogoevski D, Izbicki J, Kutup A
SCI REP-UK. 2018;8(1):17370.

High expression of class III β-tubulin in upper gastrointestinal cancer types
Höflmayer D, Öztürk E, Schroeder C, Hube-Magg C, Blessin N, Simon R, Lang D, Neubauer E, Göbel C, Heinrich M, Fraune C, Möller K, Armbrust M, Freytag M, Hinsch A, Lühr C, Noack M, Reiswich V, Weidemann S, Bockhorn M, Perez D, Izbicki J, Sauter G, Jacobsen F
ONCOL LETT. 2018;16(6):7139-7145.

EXPRESSION OF TN ANTIGEN PROMOTES PANCREATIC CARCINOGENESIS IN A TRANSGENIC MOUSE MODEL
Mercanoglu B, Wolters-Eisfeld G, Güngör C, Izbicki J, Bockhorn M
UNITED EUR GASTROENT. 2018.

CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation
Wittner M, Dunay G, Kummer S, Bockhorn M, Hüfner A, Schmiedel S, Degen O, van Lunzen J, Eberhard J, Schulze Zur Wiesch J
JAIDS-J ACQ IMM DEF. 2018;77(4):345-349.

Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer
Woestemeier A, Ghadban T, Riethdorf S, Harms-Effenberger K, Konczalla L, Uzunoglu F, Izbicki J, Pantel K, Bockhorn M, Reeh M
ANTICANCER RES. 2018;38(10):5665-5669.

Loss of complex O-glycosylation impairs exocrine pancreatic function and induces MODY8-like diabetes in mice
Wolters-Eisfeld G, Mercanoglu B, Hofmann B, Wolpers T, Schnabel C, Harder S, Steffen P, Bachmann K, Steglich B, Schrader J, Gagliani N, Schlüter H, Güngör C, Izbicki J, Wagener C, Bockhorn M
EXP MOL MED. 2018;50(10):1-13.

Pankreasanastomosen bei operativer Versorgung der chronischen Pankreatitis
Bellon E, Izbicki J, Bockhorn M
CHIRURG. 2017;88(1):18-24.

HRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer
Bogoevska V, Wolters-Eisfeld G, Hofmann B, El Gammal A, Mercanoglu B, Gebauer F, Vashist Y, Bogoevski D, Perez D, Gagliani N, Izbicki J, Bockhorn M, Güngör C
ONCOGENE. 2017;36(17):2394-2404.

Protein S100A8/A9: A Potential New Biomarker for Pancreatic Diseases
El Gammal A, Sturm J, Pinnschmidt H, Hofmann B, Bellon E, Ghadban T, Melling N, Bachmann K, Izbicki J, Bockhorn M, Güngör C, Perez D
Int J Clin Endocrinol Metab. 2017;3(1):023-028.

Wie weit ist die laparoskopische Resektion eines kolorektalen Karzinoms in Deutschland?: Eine deutschlandweite Erhebung der Mortalität, Morbidität und angewandten Operationsmethode
Ghadban T, Reeh M, Bockhorn M, Perez D
Z GASTROENTEROL. 2017;55(08):e57-e299.

TRYPTOPHAN DEGRADATION AS AN ALTERNATIVE ENERGY SOURCE IN PANCREATIC CANCER
Güngör C, Mercanoglu B, Wolters-Eisfeld G, Izbicki J, Bockhorn M
UNITED EUR GASTROENT. 2017;5: Supplement 1.

The Diagnosis and Treatment of Hemoptysis
Ittrich H, Bockhorn M, Klose H, Simon M
DTSCH ARZTEBL INT. 2017;114(21):371-381.

Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression
Kim E, Ackermann C, Tóth I, Dierks P, Eberhard J, Wroblewski R, Scherg F, Geyer M, Schmidt R, Beisel C, Bockhorn M, Haag F, Lunzen J, Schulze Zur Wiesch J
J LEUKOCYTE BIOL. 2017;101(5):1263-1271.

Hypoxie induzierte und HIF1A vermittelte differentielle O-Glykosylierung reguliert onkogene Signalwege im duktalen Adenokarzinom des Pankreas
Mercanoglu B, Güngör C, Bockhorn M, Wolters-Eisfeld G
Z GASTROENTEROL. 2017;55(08):KV 222.

HYPOXIA INDUCED HIF1A-MEDIATED DIFFERENTIAL O-GALNAC GLYCOSYLATION DIRECTLY REGULATES SIGNALING PATHWAYS IN PANCREATIC CANCER
Mercanoglu B, Hofmann B, Güngör C, Izbicki J, Bockhorn M, Wolters-Eisfeld G
UNITED EUR GASTROENT. 2017.

Expression of Tn Antigen Causes Chronic Pancreatitis in a Transgenic Mouse Model
Mercanoglu B, Karstens K, Güngör C, Izbicki J, Bockhorn M, Wolters-Eisfeld G
EUR SURG RES. 2017.

EXPRESSION OF TN ANTIGEN CAUSES CHRONIC PANCREATITIS IN A TRANSGENIC MOUSE MODEL
Mercanoglu B, Karstens K, Güngör C, Izbicki J, Bockhorn M, Wolters-Eisfeld G
UNITED EUR GASTROENT. 2017.

Die Expression des Tn Antigens begünstigt die pankreatische Karzinogenese in einem transgenen Mausmodell
Mercanoglu B, Wolters-Eisfeld G, Güngör C, Izbicki J, Bockhorn M
Z GASTROENTEROL. 2017.

DIFFERENTIALLY O-GLYCOSYLATED CARBOXYL ESTER LIPASE CAUSES A MODY8-LIKE PHENOTYPE IN MICE
Mercanoglu B, Wolters-Eisfeld G, Güngör C, Izbicki J, Bockhorn M
UNITED EUR GASTROENT. 2017.

Totale Pankreatektomie
Nentwich M, Bockhorn M, Izbicki J
2017. Expertise Pankreas. Izbicki J, Perez D (Hrsg.). 1. Aufl. Georg Thieme Verlag KG, 78-82.

Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs)
Nentwich M, Menzel K, Reeh M, Uzunoglu F, Ghadban T, Bachmann K, Schrader J, Bockhorn M, Izbicki J, Perez D
EJSO-EUR J SURG ONC. 2017;43(4):758-762.

Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
Reeh M, Ghadban T, Uzunoglu F, Nentwich M, Bockhorn M, Pantel K, Izbicki J, Vashist Y
BRIT J CANCER. 2017;117(5):612-618.

Hypoxia induced HIF1a-mediated O-GalNAc glycosylation of cytosolic O-GlcNAcylated proteins to regulate signaling pathways in pancreatic cancer.
Wolters-Eisfeld G, Mercanoglu B, Güngör C, Izbicki J, Bockhorn M
J CLIN ONCOL. 2017;35(15_suppl):e15739-e15739.

Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer
Yang S, Che S, Kurywchak P, Tavormina J, Gansmo L, Correa de Sampaio P, Tachezy M, Bockhorn M, Gebauer F, Haltom A, Melo S, LeBleu V, Kalluri R
CANCER BIOL THER. 2017;18(3):158-165.

Pancreatic cancer and liver metastases: state of the art
Bellon E, Gebauer F, Tachezy M, Izbicki J, Bockhorn M
UPDATES SURG. 2016;68(3):247-251.

Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery
Besselink M, van Rijssen L, Bassi C, Dervenis C, Montorsi M, Adham M, Asbun H, Bockhorn M, Strobel O, Büchler M, Busch O, Charnley R, Conlon K, Fernández-Cruz L, Fingerhut A, Friess H, Izbicki J, Lillemoe K, Neoptolemos J, Sarr M, Shrikhande S, Sitarz R, Vollmer C, Yeo C, Hartwig W, Wolfgang C, Gouma D
SURGERY. 2016;161(2):365-372.

Tenascin-C serum levels and its prognostic power in non-small cell lung cancer
Gebauer F, Gelis S, Zander H, Meyer K, Wolters-Eisfeld G, Izbicki J, Bockhorn M, Tachezy M
ONCOTARGET. 2016;7(15):20945-52.

Establishment and Characterization of a Pair of Patient-derived Human Non-small Cell Lung Cancer Cell Lines from a Primary Tumor and Corresponding Lymph Node Metastasis
Gebauer F, Wicklein D, Tachezy M, Grob T, Steinemann D, Manukjan G, Göhring G, Schlegelberger B, Maar H, Izbicki J, Bockhorn M, Schumacher U
ANTICANCER RES. 2016;36(4):1507-18.

Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer.
Hofmann B, Kwiatkowski M, Izbicki J, Bockhorn M, Güngör C, Ewald F, Wolters-Eisfeld G
J CLIN ONCOL. 2016;34(15_suppl):e15673-e15673.

Non-trauma Emergency Pancreatoduodenectomies: A Single-Center Retrospective Analysis
Nentwich M, Reeh M, Uzunoglu F, Bachmann K, Bockhorn M, Izbicki J, Vashist Y
WORLD J SURG. 2016;40(9):2261-6.

Combined modified en bloc corpectomy with replacement of the aorta in curative interdisciplinary treatment of a large osteosarcoma infiltrating the aorta
Pilger A, Tsilimparis N, Bockhorn M, Trepel M, Dreimann M
EUR SPINE J. 2016;25 (Suppl 1):58-62.

The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer
Reeh M, Metze J, Uzunoglu F, Nentwich M, Ghadban T, Wellner U, Bockhorn M, Kluge S, Izbicki J, Vashist Y
MEDICINE. 2016;95(7):e2724.

Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer
Schirmer M, Lüske C, Roppel S, Schaudinn A, Zimmer C, Pflüger R, Haubrock M, Rapp J, Güngör C, Bockhorn M, Hackert T, Hank T, Strobel O, Werner J, Izbicki J, Johnsen S, Gaedcke J, Brockmöller J, Ghadimi B
JNCI-J NATL CANCER I. 2016;108(5):djv387.

Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis
Tachezy M, Gebauer F, Janot M, Uhl W, Zerbi A, Montorsi M, Perinel J, Adham M, Dervenis C, Agalianos C, Malleo G, Maggino L, Stein A, Izbicki J, Bockhorn M
SURGERY. 2016;160(1):136-44.

The Effects of Pancreatic Microcirculatory Disturbances on Histopathologic Tissue Damage and the Outcome in Severe Acute Pancreatitis
Tomkötter L, Erbes P, Trepte C, Hinsch A, Dupree A, Bockhorn M, Mann O, Izbicki J, Bachmann K
PANCREAS. 2016;45(2):248-253.

Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma
Wachowiak R, Mayer S, Kaifi J, Gebauer F, Izbicki J, Lacher M, Bockhorn M, Tachezy M
ANTICANCER RES. 2016;36(8):3991-5.

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry
Bachmann K, Neumann A, Hinsch A, Nentwich M, El Gammal A, Vashist Y, Perez D, Bockhorn M, Izbicki J, Mann O
J SURG ONCOL. 2015;111(3):316-23.

Roboter assistierte versus offene Chirurgie bei tiefem Rektumkarzinom - Initiale Erfahrung in Hamburg-Eppendorf
Baukloh J, Reeh M, Bockhorn M, Hiller J, Izbicki J, Perez D
2015. 195. Sommertagung der Vereinigung Norddeutscher Chirurgen. .

Roboter-assistierte versus offene tiefe anteriore Rektumresektion – Initiale Erfahrung im Hamburg-Eppendorf
Baukloh J, Reeh M, Bockhorn M, Izbicki J, Perez D
Z GASTROENTEROL. 2015.

Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic?
Gebauer F, Tachezy M, Vashist Y, Marx A, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(2):493-9.

COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer
Hofmann B, Schlüter L, Lange P, Mercanoglu B, Ewald F, Fölster A, Picksak A, Harder S, El Gammal A, Grupp K, Güngör C, Drenckhan A, Schlüter H, Wagener C, Izbicki J, Jücker M, Bockhorn M, Wolters-Eisfeld G
MOL CANCER. 2015;14(1):109.

Salvage Completion Pancreatectomies as Damage Control for Post-pancreatic Surgery Complications: A Single-Center Retrospective Analysis
Nentwich M, El Gammal A, Lemcke T, Ghadban T, Bellon E, Melling N, Bachmann K, Reeh M, Uzunoglu F, Izbicki J, Bockhorn M
WORLD J SURG. 2015;39(6):1550-6.

Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
Reeh M, Harms-Effenberger K, Koenig A, Riethdorf S, Eichstädt D, Vettorazzi E, Uzunoglu F, Vashist Y, Izbicki J, Pantel K, Bockhorn M
ANN SURG. 2015;261(6):1124-30.

Locally advanced esophageal carcinoma: is there still a role of surgery alone without neoadjuvant treatment?
Reeh M, Nentwich M, Asani S, Uzunoglu F, Bockhorn M, Sauter G, Rösch T, Izbicki J, Bogoevski D
J GASTROINTEST SURG. 2015;19(4):587-93.

Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1
Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre J, Banchereau J, Levy Y, Seddiki N
AIDS. 2015;29(5):519-30.

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
Stahl P, Seeschaaf C, Lebok P, Kutup A, Bockhorn M, Izbicki J, Bokemeyer C, Simon R, Sauter G, Marx A
BMC GASTROENTEROL. 2015;15(1):7.

When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery
Asbun H, Conlon K, Fernandez-Cruz L, Riess H, Shrikhande S, Adham M, Bassi C, Bockhorn M, Büchler M, Charnley R, Dervenis C, Fingerhutt A, Gouma D, Hartwig W, Imrie C, Izbicki J, Lillemoe K, Milicevic M, Montorsi M, Neoptolemos J, Sandberg A, Sarr M, Vollmer C, Yeo C, Traverso L
SURGERY. 2014;155(5):887-892.

Beger and Frey Procedures for Treatment of Chronic Pancreatitis: Comparison of Outcomes at 16-Year Follow-Up
Bachmann K, Tomkoetter L, Erbes P, Hofmann B, Reeh M, Perez D, Vashist Y, Bockhorn M, Izbicki J, Mann O
J AM COLL SURGEONS. 2014;219(2):208-216.

Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Bockhorn M, Uzunoglu F, Adham M, Imrie C, Milicevic M, Sandberg A, Asbun H, Bassi C, Büchler M, Charnley R, Conlon K, Cruz L, Dervenis C, Fingerhutt A, Friess H, Gouma D, Hartwig W, Lillemoe K, Montorsi M, Neoptolemos J, Shrikhande S, Takaori K, Traverso W, Vashist Y, Vollmer C, Yeo C, Izbicki J
SURGERY. 2014;155(6):977-988.

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression
Eberhard J, Hartjen P, Kummer S, Schmidt R, Bockhorn M, Lehmann C, Balagopal A, Hauber J, Lunzen J, Schulze zur Wiesch J
PLOS ONE. 2014;9(11):e111323.

The role of RANK-signaling in tumor cell proliferation and migration in pancreatic adenocarcinoma.
El Gammal A, Sander N, Aljonna F, Friedenberger H, Leonie K, Güngör C, Wolters-Eisfeld G, Hofmann B, Bockhorn M, Izbicki J, Perez D
2014. J Clin Oncol. suppl; abstr e15193.

Predictive Factors for Postoperative Pancreatic Fistula - Reply
Gebauer F, Izbicki J, Bockhorn M
ANN SURG. 2014;261(4):E99-E100.

Serum EpCAM expression in pancreatic cancer
Gebauer F, Struck L, Tachezy M, Vashist Y, Wicklein D, Schumacher U, Izbicki J, Bockhorn M
ANTICANCER RES. 2014;34(9):4741-4746.

Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer
Gebauer F, Wicklein D, Horst J, Sundermann P, Maar H, Streichert T, Tachezy M, Izbicki J, Bockhorn M, Schumacher U
PLOS ONE. 2014;9(11):e113023.

Expression of cancer testis antigens CT10 (MAGE-C2) and GAGE in gastrointestinal stromal tumors
Ghadban T, Perez D, Vashist Y, Bockhorn M, Koenig A, El Gammal A, Izbicki J, Metzger U, Hauswirth F, Frosina D, Jungbluth A
EJSO-EUR J SURG ONC. 2014;40(10):1307-1312.

Pancreatic cancer
Güngör C, Hofmann B, Wolters-Eisfeld G, Bockhorn M
BRIT J PHARMACOL. 2014;171(4):849-858.

Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)
Hartwig W, Vollmer C, Fingerhut A, Yeo C, Neoptolemos J, Adham M, Andrén-Sandberg A, Asbun H, Bassi C, Bockhorn M, Charnley R, Conlon K, Dervenis C, Fernandez-Cruz L, Friess H, Gouma D, Imrie C, Lillemoe K, Milićević M, Montorsi M, Shrikhande S, Vashist Y, Izbicki J, Büchler M
SURGERY. 2014;156(1):1-14.

ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer
Hofmann B, Stehr A, Dohrmann T, Güngör C, Herich L, Hiller J, Harder S, Ewald F, Gebauer F, Tachezy M, Precht C, Izbicki J, Bockhorn M, Wagener C, Wolters-Eisfeld G
CLIN CANCER RES. 2014;20(23):6117-26.

Zertifizierungen in der onkologischen Chirurgie: Bedeutung für die Wahl der Behandlungsstätte
Melling N, Drabik A, El Gammal A, Antonakis F, Darmann I, Izbicki J, Bockhorn M
CHIRURG. 2014;86(7):687-695.

The multifunctional growth factor midkine promotes proliferation and migration in pancreatic cancer
Rawnaq T, Dietrich L, Wolters-Eisfeld G, Uzunoglu F, Vashist Y, Bachmann K, Simon R, Izbicki J, Bockhorn M, Güngör C
MOL CANCER RES. 2014;12(5):670-80.

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)
Tachezy M, Gebauer F, Petersen C, Arnold D, Trepel M, Wegscheider K, Schafhausen P, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2014;14(1):411.

Activated Leukocyte Cell Adhesion Molecule (CD166): An "Inert" Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki J, Bockhorn M
STEM CELLS. 2014;32(6):1429-1436.

Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
Tol J, Gouma D, Bassi C, Dervenis C, Montorsi M, Adham M, Andrén-Sandberg A, Asbun H, Bockhorn M, Büchler M, Conlon K, Fernández-Cruz L, Fingerhut A, Friess H, Hartwig W, Izbicki J, Lillemoe K, Milicevic M, Neoptolemos J, Shrikhande S, Vollmer C, Yeo C, Charnley R
SURGERY. 2014;156(3):591-600.

Loss of 4q21.23-22.1 is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
Uzunoglu F, Dethlefsen E, Hanssen A, Wrage M, Deutsch L, Harms-Effenberger K, Vashist Y, Reeh M, Sauter G, Simon R, Bockhorn M, Pantel K, Izbicki J, Wikman-Kocher H
PLOS ONE. 2014;9(12):e113315.

Preoperative Pancreatic Resection (PREPARE) score: a prospective multicenter-based morbidity risk score
Uzunoglu F, Reeh M, Vettorazzi E, Ruschke T, Hannah P, Nentwich M, Vashist Y, Bogoevski D, König A, Janot M, Gavazzi F, Zerbi A, Todaro V, Malleo G, Uhl W, Montorsi M, Bassi C, Izbicki J, Bockhorn M
ANN SURG. 2014;260(5):857-64.

Single versus double Roux-en-Y reconstruction techniques in pancreaticoduodenectomy: a comparative single-center study
Uzunoglu F, Reeh M, Wollstein R, Melling N, Perez D, Vashist Y, Bogoevski D, Izbicki J, Bockhorn M
WORLD J SURG. 2014;38(12):3228-3234.

Is the Whipple procedure harmful for long-term outcome in treatment of chronic pancreatitis? 15-years follow-up comparing the outcome after pylorus-preserving pancreatoduodenectomy and Frey procedure in chronic pancreatitis
Bachmann K, Tomkoetter L, Kutup A, Erbes P, Vashist Y, Mann O, Bockhorn M, Izbicki J
ANN SURG. 2013;258(5):815-20; discussion 820-1.

Altered PTEN function caused by deletion or gene disruption is associated with poor prognosis in rectal but not in colon cancer
Bohn B, Mina S, Krohn A, Simon R, Kluth M, Harasimowicz S, Quaas A, Bockhorn M, Izbicki J, Sauter G, Marx A, Stahl P
HUM PATHOL. 2013;44(8):1524-33.

Selectin binding is essential for peritoneal carcinomatosis in a xenograft model of human pancreatic adenocarcinoma in pfp--/rag2-- mice
Gebauer F, Wicklein D, Stübke K, Nehmann N, Schmidt A, Salamon J, Peldschus K, Nentwich M, Adam G, Tolstonog G, Bockhorn M, Izbicki J, Wagener C, Schumacher U
GUT. 2013;62(5):741-50.

Abdominal pain in a patient with a complex history (case report)
Guthoff A, Schulze zur Wiesch C, Berliner C, Quaas A, Lange M, Bockhorn M
ULTRASCHALL MED. 2013;34(S 01):PS3_07.

Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor).
Izbicki J, Tsui T, Bohn B, Bockhorn M
J GASTROINTEST SURG. 2013;17(3):581-585.

Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma
König A, Reeh M, Dancau A, Rathjens M, Gros S, Uzunoglu F, Bockhorn M, Simon R, Sauter G, Marx A, Izbicki J
ANTICANCER RES. 2013;33(11):4975-82.

Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer
Nentwich M, Bohn B, Uzunoglu F, Reeh M, Quaas A, Grob T, Perez D, Kutup A, Bockhorn M, Izbicki J, Vashist Y
J THORAC CARDIOV SUR. 2013;146(4):781-7.

Protein domain histochemistry (PDH): binding of the carbohydrate recognition domain (CRD) of recombinant human glycoreceptor CLEC10A (CD301) to formalin-fixed, paraffin-embedded breast cancer tissues.
Nollau P, Wolters-Eisfeld G, Seyed Mortezai N, Kurze A, Klampe B, Debus A, Bockhorn M, Niendorf A, Wagener C
J HISTOCHEM CYTOCHEM. 2013;61(3):199-205.

Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis
Reeh M, Bockhorn M, Görgens D, Vieth M, Hoffmann T, Simon R, Izbicki J, Sauter G, Schumacher U, Anders M
BRIT J CANCER. 2013;109(7):1848-58.

Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1
Salamon J, Derlin T, Bannas P, Busch J, Herrmann J, Bockhorn M, Hagel C, Friedrich R, Adam G, Mautner V
EUR J NUCL MED MOL I. 2013;40(5):685-92.

CXCR7 expression in esophageal cancer
Tachezy M, Zander H, Gebauer F, Loga K, Pantel K, Izbicki J, Bockhorn M
J TRANSL MED. 2013;11:238.

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion
Tóth I, Le A, Hartjen P, Thomssen A, Matzat V, Lehmann C, Scheurich C, Beisel C, Busch C, Degen O, Lohse A, Eiermann T, Fätkenheuer G, Meyer-Olson D, Bockhorn M, Hauber J, Lunzen J, Schulze Zur Wiesch J
J LEUKOCYTE BIOL. 2013;94(4):551-61.

LigaSure™ vs. conventional dissection techniques in pancreatic surgery--a prospective randomised single-centre trial.
Uzunoglu F, Bockhorn M, Fink J, Reeh M, Vettorazzi E, Gawad K, Bogoevski D, Vashist Y, Tsui T, Koenig A, Mann O, Izbicki J
J GASTROINTEST SURG. 2013;17(3):494-500.

VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma
Uzunoglu F, Kolbe J, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, König A, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN ONCOL. 2013;24(5):1282-90.

C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC
Uzunoglu F, Yavari N, Bohn B, Nentwich M, Reeh M, Pantel K, Perez D, Tsui T, Bockhorn M, Mann O, Izbicki J, Wikman H, Vashist Y
LUNG CANCER. 2013;81(1):123-9.

Options and limitations in applying the fistula classification by the International Study Group for Pancreatic Fistula
Gebauer F, Kloth K, Tachezy M, Vashist Y, Cataldegirmen G, Izbicki J, Bockhorn M, Bockhorn M
ANN SURG. 2012;256(1):130-8.

Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival.
Harms-Effenberger K, Schröder C, Zu Eulenburg C, Reeh M, Tachezy M, Riethdorf S, Vashist Y, Izbicki J, Pantel K, Bockhorn M
INT J CANCER. 2012;131(4):475-483.

Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.
König A, Reeh M, Burdelski C, Wengert C, Gawad K, Izbicki J, Bockhorn M
LANGENBECK ARCH SURG. 2012;397(8):1251-1259.

Surgery for advanced and metastatic pancreatic cancer--current state and trends
Nentwich M, Bockhorn M, König A, Izbicki J, Cataldegirmen G
ANTICANCER RES. 2012;32(5):1999-2002.

Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction
Reeh M, Mina S, Bockhorn M, Kutup A, Nentwich M, Marx A, Sauter G, Rösch T, Izbicki J, Bogoevski D
BRIT J SURG. 2012;99(10):1406-14.

An attempt at validation of the Seventh edition of the classification by the International Union Against Cancer for esophageal carcinoma.
Reeh M, Nentwich M, von Loga K, Schade J, Uzunoglu F, König A, Bockhorn M, Rösch T, Izbicki J, Bogoevski D
ANN THORAC SURG. 2012;93(3):890-896.

ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients
Tachezy M, Harms-Effenberger K, Zander H, Minner S, Gebauer F, Vashist Y, Sauter G, Pantel K, Izbicki J, Bockhorn M
INT J CANCER. 2012;131(2):396-405.

Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients
Tachezy M, Zander H, Gebauer F, Marx A, Kaifi J, Izbicki J, Bockhorn M
J SURG RES. 2012;177(1):e15-20.

ALCAM (CD166) expression and serum levels in pancreatic cancer
Tachezy M, Zander H, Marx A, Stahl P, Gebauer F, Izbicki J, Bockhorn M
PLOS ONE. 2012;7(6):e39018.

Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
Uzunoglu F, Kaufmann C, Wikman H, Güngör C, Bohn B, Nentwich M, Reeh M, Pantel K, Bockhorn M, Kutup A, Mann O, Izbicki J, Vashist Y
ANN SURG ONCOL. 2012;19(7):2159-2168.

Notfallsternotomie bei perkutaner zentralvenöser Punktion - ein Fallbericht
Uzunoglu F, Koenig A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-3.

[Emergency sternotomy during percutaneous central venous catheterisation - a case report].
Uzunoglu F, König A, Bockhorn M, Cataldegirmen G, Izbicki J, Benhidjeb T
ZBL CHIR. 2012;137(3):262-263.

Ultrasonic dissection versus conventional dissection techniques in pancreatic surgery: a randomized multicentre study.
Uzunoglu F, Stehr A, Fink J, Vettorazzi E, König A, Gawad K, Vashist Y, Kutup A, Mann O, Gavazzi F, Zerbi A, Bassi C, Dervenis C, Montorsi M, Bockhorn M, Izbicki J
ANN SURG. 2012;256(5):675-680.

Impact of early or delayed elective resection in complicated diverticulitis.
Bachmann K, Krause G, Rawnaq T, Tomkötter L, Vashist Y, Shahmiri S, Izbicki J, Bockhorn M
WORLD J GASTROENTERO. 2011;17(48):5274-5279.

Arterial en bloc resection for pancreatic carcinoma.
Bockhorn M, Burdelski C, Bogoevski D, Sgourakis G, Yekebas E, Izbicki J
BRIT J SURG. 2011;98(1):86-92.

Chronic pancreatitis complicated by cavernous transformation of the portal vein: contraindication to surgery?
Bockhorn M, Gebauer F, Bogoevski D, Molmenti E, Cataldegirmen G, Vashist Y, Yekebas E, Izbicki J, Mann O
SURGERY. 2011;149(3):321-328.

How radical should surgery be for early esophageal cancer?
Bogoevski D, Bockhorn M, König A, Reeh M, von Loga K, Sauter G, Rösch T, Izbicki J
WORLD J SURG. 2011;35(6):1311-1320.

Multivisceral resections in pancreatic cancer: identification of risk factors.
Burdelski C, Reeh M, Bogoevski D, Gebauer F, Tachezy M, Vashist Y, Cataldegirmen G, Yekebas E, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(12):2756-2763.

Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
Gebauer F, Tachezy M, Harms-Effenberger K, von Loga K, Zander H, Marx A, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG ONCOL. 2011;104(2):140-145.

Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.
Güngör C, Zander H, Harms-Effenberger K, Vashist Y, Kalinina T, Izbicki J, Yekebas E, Bockhorn M
CANCER RES. 2011;71(14):5009-5019.

High surgical morbidity following distal pancreatectomy: still an unsolved problem.
Reeh M, Nentwich M, Bogoevski D, König A, Gebauer F, Tachezy M, Izbicki J, Bockhorn M
WORLD J SURG. 2011;35(5):1110-1117.

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?
Tachezy M, Bockhorn M, Gebauer F, Vashist Y, Kaifi J, Izbicki J
J GASTROINTEST SURG. 2011;15(5):829-835.

ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.
Tachezy M, Zander H, Marx A, Gebauer F, Rawnaq T, Kaifi J, Sauter G, Izbicki J, Bockhorn M
J SURG RES. 2011;170(2):226-232.

The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist Y, Kutup A, Musici S, Yekebas E, Mina S, Uzunoglu F, Zehler O, König A, Cataldegirmen G, Bockhorn M, Harms-Effenberger K, Kalinin V, Pantel K, Izbicki J
MOL CELL ONCOL. 2011;34(4):281-288.

Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.
Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G, Bockhorn M, Schachner M, Izbicki J, Kaifi J
BMC CANCER. 2011;11:1-7.

Training innovations in gastroenterology and educational resources: a new vision of gastrointestinal education across Europe.
Berberat P, Wit d, Bockhorn M, Bockhorn M, Lundell L, Drenth J
EUR J GASTROEN HEPAT. 2010;22(12):1393-1396.

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T, Bockhorn M, Kaifi J, Thieltges S, Güngör C, Harms-Effenberger K, Strelow A, Reichelt U, Sauter G, Pantel K, Izbicki J, Yekebas E
INT J CANCER. 2010;127(8):1931-1940.

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
Kalinina T, Güngör C, Thieltges S, Möller-Krull M, Murga-Penas E, Wicklein D, Streichert T, Schumacher U, Kalinin V, Simon R, Otto B, Dierlamm J, Schwarzenbach H, Harms-Effenberger K, Bockhorn M, Izbicki J, Yekebas E
BMC CANCER. 2010;10:295.

Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue--influence of a modulated host stroma on the prognosis of HCC.
Simon F, Bockhorn M, Praha C, Baba H, Broelsch C, Frilling A, Weber F
LANGENBECK ARCH SURG. 2010;395(4):395-405.

Quo vadis STARR?: A prospective long-term follow-up of stapled transanal rectal resection for obstructed defecation syndrome
Zehler O, Vashist Y, Bogoevski D, Bockhorn M, Yekebas E, Izbicki J, Kutup A, Bockhorn M
J GASTROINTEST SURG. 2010;14(9):1349-54.

Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.
Bockhorn M, Cataldegirmen G, Kutup A, Marx A, Burdelski C, Vashist Y, Mann O, Deutsch L, König A, Izbicki J, Yekebas E
ANN SURG ONCOL. 2009;16(5):1212-1221.

Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases.
Bockhorn M, Sotiropoulos G, Neuhaus J, Sgourakis G, Sheu S, Molmenti E, Fingas C, Trarbach T, Frilling A, Broelsch C
INT J COLORECTAL DIS. 2009;24(7):845-850.

Major liver resections in the elderly-is an aggressive approach justified?
Bockhorn M, Sotiropoulos G, Sgourakis G, Neuhaus J, Molmenti E, Lang H, Frilling A, Broelsch C
INT J COLORECTAL DIS. 2009;24(1):83-86.

Extended central pancreatic resection as an alternative for extended left or extended right resection for appropriate pancreatic neoplasms.
Cataldegirmen G, Schneider C, Bogoevski D, König A, Kaifi J, Bockhorn M, Deutsch L, Vashist Y, Izbicki J, Yekebas E
SURGERY. 2009.

Impact of KIT and PDGFRA gene mutations on prognosis of patients with gastrointestinal stromal tumors after complete primary tumor resection.
Hou Y, Grabellus F, Weber F, Zhou Y, Tan Y, Li J, Shen K, Qin J, Sun Y, Qin X, Bockhorn M, Gerken G, Broelsch C, Frilling A
J GASTROINTEST SURG. 2009;13(9):1583-1592.

Major liver resections for primary liver malignancies in the elderly.
Sgourakis G, Sotiropoulos G, Bockhorn M, Fouzas I, Radtke A, Molmenti E, Drühe N, Broelsch C, Karaliotas C, Lang H
ACTA CHIR BELG. 2009;109(3):340-344.

COX-2 expression in highly aggressive thyroid malignancies - indication for a possible therapeutic option?
Sheu S, Grabellus F, Schwertheim S, Mann K, Ensinger C, Ofner D, Bockhorn M, Fuhrer D, Schmid K
HORM METAB RES. 2009;41(4):314-319.

R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis
Sotiropoulos G, Bockhorn M, Sgourakis G, Brokalaki E, Molmenti E, Neuhäuser M, Radtke A, Wohlschlaeger J, Baba H, Broelsch C, Lang H
DIGEST DIS SCI. 2009;54(4):887-94.

Impact of hepatic vein deprivation on liver regeneration and function after major hepatectomy.
Bockhorn M, Benkö T, Opitz B, Sheu S, Sotiropoulos G, Schlaak J, Broelsch C, Lang H
LANGENBECK ARCH SURG. 2008;393(4):527-533.

Erythropoietin treatment improves liver regeneration and survival in rat models of extended liver resection and living donor liver transplantation
Bockhorn M, Fingas C, Rauen U, Canbay A, Sotiropoulos G, Frey U, Sheu S, Wohlschläger J, Broelsch C, Schlaak J
TRANSPLANTATION. 2008;86(11):1578-85.

Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?
Bockhorn M, Frilling A, Frühauf N, Neuhaus J, Molmenti E, Trarbach T, Malagó M, Lang H, Broelsch C
J GASTROINTEST SURG. 2008;12(8):1399-405.

Hepatocellular carcinoma as a coincidental finding in a patient undergoing surgery for focal nodular hyperplasia
Sotiropoulos G, Bockhorn M, Molmenti E, Fouzas I, Broelsch C, Lang H
LIVER INT. 2008;28(4):578-9.

Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience
Sotiropoulos G, Kaiser G, Lang H, Molmenti E, Beckebaum S, Fouzas I, Sgourakis G, Radtke A, Bockhorn M, Nadalin S, Treckmann J, Niebel W, Baba H, Broelsch C, Paul A
TRANSPL P. 2008;40(9):3194-5.

Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience
Sotiropoulos G, Lang H, Saner F, Beckebaum S, Wandelt M, Molmenti E, Nadalin S, Treckmann J, Bockhorn M, Fouzas I, Malagó M, Gerken G, Broelsch C, Paul A
TRANSPL P. 2008;40(9):3196-7.

Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?
Sotiropoulos G, Malagó M, Bockhorn M, Schmitz K, Radtke A, Molmenti E, Schaffer R, Beckebaum S, Cicinnati V, Fouzas I, Broelsch C, Lang H
HEPATO-GASTROENTEROL. 2008;55(86-87):1671-7.

Tri-iodothyronine as a stimulator of liver regeneration after partial and subtotal hepatectomy.
Bockhorn M, Frilling A, Benko T, Best J, Sheu S, Trippler M, Schlaak J, Broelsch C
EUR SURG RES. 2007;39(1):58-63.

VEGF is important for early liver regeneration after partial hepatectomy.
Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grünewald P, Trippler M, Biglarnia A, Kamler M, Niehues E, Frilling A, Broelsch C, Schlaak J
J SURG RES. 2007;138(2):291-299.

Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?
Bockhorn M, Jain R, Munn L
LANCET ONCOL. 2007;8(5):444-448.

Vascular endothelial growth factor does not improve liver regeneration and survival after 90% subtotal liver resection.
Bockhorn M, Schöllmann S, Opitz B, Sotiropoulos G, Sheu S, Niehaus E, Trippler M, Frilling A, Broelsch C, Schlaak J
HEPATOL RES. 2007;37(5):353-359.

Computer-assisted operative planning in adult living donor liver transplantation: a new way to resolve the dilemma of the middle hepatic vein.
Radtke A, Nadalin S, Sotiropoulos G, Molmenti E, Schroeder T, Valentin-Gamazo C, Lang H, Bockhorn M, Peitgen H, Broelsch C, Malagó M
WORLD J SURG. 2007;31(1):175-185.

The role of surgery in Caroli's disease
Bockhorn M, Malagó M, Lang H, Nadalin S, Paul A, Saner F, Frilling A, Broelsch C
J AM COLL SURGEONS. 2006;202(6):928-32.

Living donor liver transplantation
Nadalin S, Bockhorn M, Malagó M, Valentin-Gamazo C, Frilling A, Broelsch C
HPB. 2006;8(1):10-21.

Computer-gestützte Operationsplanung bei Leberlebendspenden
Radtke A, Bockhorn M, Schroeder T, Lang H, Paul A, Nadalin S, Saner F, Schenk A, Broelsch C, Malagó M
ZBL CHIR. 2006;131(1):69-74.

Effects of positive end-expiratory pressure on systemic haemodynamics, with special interest to central venous and common iliac venous pressure in liver transplanted patients
Saner F, Pavlakovic G, Gu Y, Gensicke J, Paul A, Radtke A, Bockhorn M, Fruhauf N, Nadalin S, Malagó M, Broelsch C
EUR J ANAESTH. 2006;23(9):766-71.

Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria
Sotiropoulos G, Molmenti E, Omar O, Bockhorn M, Brokalaki E, Lang H, Frilling A, Broelsch C, Malagó M
EUR J MED RES. 2006;11(11):467-70.

Neue Techniken in der Lebertransplantation
Bockhorn M, Frilling A, Nadalin S, Weber F, Beckebaum S, Malago M, Broelsch C
Praxis (Bern 1994). 2005;94(18):735-41.

Paraganglioma-like medullary thyroid carcinoma: a rare entity
Bockhorn M, Sheu S, Frilling A, Molmenti E, Schmid K, Broelsch C
THYROID. 2005;15(12):1363-7.

Lebermetastasen möglichst resezieren
Broelsch C, Frilling A, Bockhorn M, Frühauf N, Beckebaum S, Paul A, Malago M
MMW Fortschr Med. 2005;147(1-2):21-4.

Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma
Bockhorn M, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid K, Broelsch C
THYROID. 2004;14(6):468-70.

Differential gene expression in metastasizing cells shed from kidney tumors
Bockhorn M, Roberge S, Sousa C, Jain R, Munn L
CANCER RES. 2004;64(7):2469-73.

Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts
Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch C, Fukumura D
CLIN CANCER RES. 2003;9(11):4221-6.

Telomerase activity in neuroendocrine tumors
Bockhorn M, Frilling A, Clauer U, Hertl M, Broelsch C
International journal of surgical investigation. 2000;2(3):219-25.

Absence of H- and K-ras oncogene mutations in sporadic medullary thyroid carcinoma
Bockhorn M, Frilling A, Kalinin V, Schröder S, Broelsch C
EXP CLIN ENDOCR DIAB. 2000;108(1):49-53.

Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma
Frilling A, Görges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, Broelsch C
SURGERY. 2000;128(6):1067-74.

No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma
Bockhorn M, Frilling A, Kalinin V, Schröder S, Broelsch C
LANGENBECK ARCH SURG. 1999;384(1):60-4.

Somatische RET-Protoonkogenmutationen bei sporadischem C-Zell-Carcinom der Schilddrüse
Frilling A, Bockhorn M, Kalinin V, Liedke M, Kaun M, Broelsch C
CHIRURG. 1997;68(8):789-93.

Letzte Aktualisierung aus dem FIS: 25.04.2024 - 00:51 Uhr